Leaders seek to diversify top ranks of CT bioscience
There is a growing network of women bioscience leaders in Greater New Haven and across the state. They are hoping to pool their influence to...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
There is a growing network of women bioscience leaders in Greater New Haven and across the state. They are hoping to pool their influence to...
In Connecticut, startups — predominantly technology or life sciences ventures located in Greater New Haven — hauled in more than $707 million in funding in...
Thetis Pharmaceuticals reports the launch of a new program in cancer. Thetis CEO Gary Mathias said, “We are targeting pancreatic, metastatic colorectal, small cell lung...
Pain where the jaw hinges to the skull is both common and difficult to treat. Killing off aged cells might be the secret to healing...
Bioais has reported positive results from an efficacy study of a blood-brain barrier penetrant interleukin-1 receptor inhibitor in a preclinical rodent model of multiple sclerosis....
Less than four years after a team of former Alexion Pharmaceuticals executives launched a startup to develop new therapies for severe and rare disorders, their...
InveniAI andi Sosei Group have announced a new R&D collaboration. The collaboration will combine InveniAI’s AI-powered platform, AlphaMeld®, for target discovery with Sosei Heptares’ G-protein...
A proposal authorizing $47 million in bond funds over five years for what UConn officials have termed “innovation faculty hires” was added to a bonding...
Bioasis, which is developing iproprietary platform technology for the delivery of therapeutics across the blood-brain barrier, has announced the appointment of Dave Jenkins as Chief Financial...
A proposal authorizing $47 million in bond funds over five years for what UConn officials have termed “innovation faculty hires” was added to a bonding...